1 Study Coverage 1.1 LDL Apheresis Therapy Product Introduction 1.2 Market by Type 1.2.1 Global LDL Apheresis Therapy Market Size Growth Rate by Type 1.4.2 Double Filtration LDL Apheresis Therapy 1.4.3 Cascade Filtration LDL Apheresis Therapy 1.3 Market by Application 1.3.1 Global LDL Apheresis Therapy Market Size Growth Rate by Application 1.3.2 Atherosclerosis Patient 1.3.3 Obesity Patient 1.3.4 Dyslipidemia Patient 1.3.5 Coronary Heart Disease Patient 1.3.6 Carotid Artery Disease Patient 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global LDL Apheresis Therapy Sales Estimates and Forecasts 2016-2027 2.2 Global LDL Apheresis Therapy Revenue Estimates and Forecasts 2016-2027 2.3 Global LDL Apheresis Therapy Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top LDL Apheresis Therapy Regions by Sales 2.4.1 Global Top LDL Apheresis Therapy Regions by Sales (2016-2021) 2.4.2 Global Top LDL Apheresis Therapy Regions by Sales (2022-2027) 2.5 Global Top LDL Apheresis Therapy Regions by Revenue 2.5.1 Global Top LDL Apheresis Therapy Regions by Revenue (2016-2021) 2.5.2 Global Top LDL Apheresis Therapy Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global LDL Apheresis Therapy Sales by Manufacturers 3.1.1 Global Top LDL Apheresis Therapy Manufacturers by Sales (2016-2021) 3.1.2 Global Top LDL Apheresis Therapy Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by LDL Apheresis Therapy Sales in 2020 3.2 Global LDL Apheresis Therapy Revenue by Manufacturers 3.2.1 Global Top LDL Apheresis Therapy Manufacturers by Revenue (2016-2021) 3.2.2 Global Top LDL Apheresis Therapy Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by LDL Apheresis Therapy Revenue in 2020 3.3 Global LDL Apheresis Therapy Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global LDL Apheresis Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global LDL Apheresis Therapy Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global LDL Apheresis Therapy Sales by Type 4.1.1 Global LDL Apheresis Therapy Historical Sales by Type (2016-2021) 4.1.2 Global LDL Apheresis Therapy Forecasted Sales by Type (2022-2027) 4.1.3 Global LDL Apheresis Therapy Sales Market Share by Type (2016-2027) 4.2 Global LDL Apheresis Therapy Revenue by Type 4.2.1 Global LDL Apheresis Therapy Historical Revenue by Type (2016-2021) 4.2.2 Global LDL Apheresis Therapy Forecasted Revenue by Type (2022-2027) 4.2.3 Global LDL Apheresis Therapy Revenue Market Share by Type (2016-2027) 4.3 Global LDL Apheresis Therapy Price by Type 4.3.1 Global LDL Apheresis Therapy Price by Type (2016-2021) 4.3.2 Global LDL Apheresis Therapy Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global LDL Apheresis Therapy Sales by Application 5.1.1 Global LDL Apheresis Therapy Historical Sales by Application (2016-2021) 5.1.2 Global LDL Apheresis Therapy Forecasted Sales by Application (2022-2027) 5.1.3 Global LDL Apheresis Therapy Sales Market Share by Application (2016-2027) 5.2 Global LDL Apheresis Therapy Revenue by Application 5.2.1 Global LDL Apheresis Therapy Historical Revenue by Application (2016-2021) 5.2.2 Global LDL Apheresis Therapy Forecasted Revenue by Application (2022-2027) 5.2.3 Global LDL Apheresis Therapy Revenue Market Share by Application (2016-2027) 5.3 Global LDL Apheresis Therapy Price by Application 5.3.1 Global LDL Apheresis Therapy Price by Application (2016-2021) 5.3.2 Global LDL Apheresis Therapy Price Forecast by Application (2022-2027) 6 North America 6.1 North America LDL Apheresis Therapy Market Size by Type 6.1.1 North America LDL Apheresis Therapy Sales by Type (2016-2027) 6.1.2 North America LDL Apheresis Therapy Revenue by Type (2016-2027) 6.2 North America LDL Apheresis Therapy Market Size by Application 6.2.1 North America LDL Apheresis Therapy Sales by Application (2016-2027) 6.2.2 North America LDL Apheresis Therapy Revenue by Application (2016-2027) 6.3 North America LDL Apheresis Therapy Market Size by Country 6.3.1 North America LDL Apheresis Therapy Sales by Country (2016-2027) 6.3.2 North America LDL Apheresis Therapy Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe LDL Apheresis Therapy Market Size by Type 7.1.1 Europe LDL Apheresis Therapy Sales by Type (2017-2027) 7.1.2 Europe LDL Apheresis Therapy Revenue by Type (2017-2027) 7.2 Europe LDL Apheresis Therapy Market Size by Application 7.2.1 Europe LDL Apheresis Therapy Sales by Application (2017-2027) 7.2.2 Europe LDL Apheresis Therapy Revenue by Application (2017-2027) 7.3 Europe LDL Apheresis Therapy Market Size by Country 7.3.1 Europe LDL Apheresis Therapy Sales by Country (2017-2027) 7.3.2 Europe LDL Apheresis Therapy Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific LDL Apheresis Therapy Market Size by Type 8.1.1 Asia Pacific LDL Apheresis Therapy Sales by Type (2018-2027) 8.1.2 Asia Pacific LDL Apheresis Therapy Revenue by Type (2018-2027) 8.2 Asia Pacific LDL Apheresis Therapy Market Size by Application 8.2.1 Asia Pacific LDL Apheresis Therapy Sales by Application (2018-2027) 8.2.2 Asia Pacific LDL Apheresis Therapy Revenue by Application (2018-2027) 8.3 Asia Pacific LDL Apheresis Therapy Market Size by Region 8.3.1 Asia Pacific LDL Apheresis Therapy Sales by Region (2018-2027) 8.3.2 Asia Pacific LDL Apheresis Therapy Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America LDL Apheresis Therapy Market Size by Type 9.1.1 Latin America LDL Apheresis Therapy Sales by Type (2019-2027) 9.1.2 Latin America LDL Apheresis Therapy Revenue by Type (2019-2027) 9.2 Latin America LDL Apheresis Therapy Market Size by Application 9.2.1 Latin America LDL Apheresis Therapy Sales by Application (2019-2027) 9.2.2 Latin America LDL Apheresis Therapy Revenue by Application (2019-2027) 9.3 Latin America LDL Apheresis Therapy Market Size by Country 9.3.1 Latin America LDL Apheresis Therapy Sales by Country (2019-2027) 9.3.2 Latin America LDL Apheresis Therapy Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa LDL Apheresis Therapy Market Size by Type 6.1.1 Middle East and Africa LDL Apheresis Therapy Sales by Type (2016-2027) 6.1.2 Middle East and Africa LDL Apheresis Therapy Revenue by Type (2016-2027) 6.2 Middle East and Africa LDL Apheresis Therapy Market Size by Application 6.2.1 Middle East and Africa LDL Apheresis Therapy Sales by Application (2016-2027) 6.2.2 Middle East and Africa LDL Apheresis Therapy Revenue by Application (2016-2027) 6.3 Middle East and Africa LDL Apheresis Therapy Market Size by Country 6.3.1 Middle East and Africa LDL Apheresis Therapy Sales by Country (2016-2027) 6.3.2 Middle East and Africa LDL Apheresis Therapy Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 UAE 11 Company Profiles 11.1 Kaneka Pharma Europe NV 11.1.1 Kaneka Pharma Europe NV Corporation Information 11.1.2 Kaneka Pharma Europe NV Overview 11.1.3 Kaneka Pharma Europe NV LDL Apheresis Therapy Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Kaneka Pharma Europe NV LDL Apheresis Therapy Product Description 11.1.5 Kaneka Pharma Europe NV Related Developments 11.2 B.Braun 11.2.1 B.Braun Corporation Information 11.2.2 B.Braun Overview 11.2.3 B.Braun LDL Apheresis Therapy Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 B.Braun LDL Apheresis Therapy Product Description 11.2.5 B.Braun Related Developments 11.3 Fresenius Medical Care 11.3.1 Fresenius Medical Care Corporation Information 11.3.2 Fresenius Medical Care Overview 11.3.3 Fresenius Medical Care LDL Apheresis Therapy Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Fresenius Medical Care LDL Apheresis Therapy Product Description 11.3.5 Fresenius Medical Care Related Developments 11.4 Asahi Kasei Medical 11.4.1 Asahi Kasei Medical Corporation Information 11.4.2 Asahi Kasei Medical Overview 11.4.3 Asahi Kasei Medical LDL Apheresis Therapy Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 Asahi Kasei Medical LDL Apheresis Therapy Product Description 11.4.5 Asahi Kasei Medical Related Developments 11.5 Medicap 11.5.1 Medicap Corporation Information 11.5.2 Medicap Overview 11.5.3 Medicap LDL Apheresis Therapy Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Medicap LDL Apheresis Therapy Product Description 11.5.5 Medicap Related Developments 11.6 Kawasumi Laboratories 11.6.1 Kawasumi Laboratories Corporation Information 11.6.2 Kawasumi Laboratories Overview 11.6.3 Kawasumi Laboratories LDL Apheresis Therapy Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Kawasumi Laboratories LDL Apheresis Therapy Product Description 11.6.5 Kawasumi Laboratories Related Developments 11.7 Terumo Corporation 11.7.1 Terumo Corporation Corporation Information 11.7.2 Terumo Corporation Overview 11.7.3 Terumo Corporation LDL Apheresis Therapy Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Terumo Corporation LDL Apheresis Therapy Product Description 11.7.5 Terumo Corporation Related Developments 11.8 Haemonetics 11.8.1 Haemonetics Corporation Information 11.8.2 Haemonetics Overview 11.8.3 Haemonetics LDL Apheresis Therapy Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Haemonetics LDL Apheresis Therapy Product Description 11.8.5 Haemonetics Related Developments 11.1 Kaneka Pharma Europe NV 11.1.1 Kaneka Pharma Europe NV Corporation Information 11.1.2 Kaneka Pharma Europe NV Overview 11.1.3 Kaneka Pharma Europe NV LDL Apheresis Therapy Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Kaneka Pharma Europe NV LDL Apheresis Therapy Product Description 11.1.5 Kaneka Pharma Europe NV Related Developments 12 Value Chain and Sales Channels Analysis 12.1 LDL Apheresis Therapy Value Chain Analysis 12.2 LDL Apheresis Therapy Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 LDL Apheresis Therapy Production Mode & Process 12.4 LDL Apheresis Therapy Sales and Marketing 12.4.1 LDL Apheresis Therapy Sales Channels 12.4.2 LDL Apheresis Therapy Distributors 12.5 LDL Apheresis Therapy Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 LDL Apheresis Therapy Industry Trends 13.2 LDL Apheresis Therapy Market Drivers 13.3 LDL Apheresis Therapy Market Challenges 13.4 LDL Apheresis Therapy Market Restraints 14 Key Findings in The Global LDL Apheresis Therapy Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global LDL Apheresis Therapy Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Double Filtration LDL Apheresis Therapy Table 3. Major Manufacturers of Cascade Filtration LDL Apheresis Therapy Table 4. Global LDL Apheresis Therapy Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global LDL Apheresis Therapy Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 6. Global LDL Apheresis Therapy Sales by Region (2016-2021) & (K Units) Table 7. Global LDL Apheresis Therapy Sales Market Share by Region (2016-2021) Table 8. Global LDL Apheresis Therapy Sales by Region (2016-2021) & (K Units) Table 9. Global LDL Apheresis Therapy Sales Market Share by Region (2022-2027) Table 10. Global LDL Apheresis Therapy Revenue by Region (2016-2021) & (US$ Million) Table 11. Global LDL Apheresis Therapy Revenue Market Share by Region (2016-2021) Table 12. Global LDL Apheresis Therapy Revenue by Region (2022-2027) & (US$ Million) Table 13. Global LDL Apheresis Therapy Revenue Market Share by Region (2022-2027) Table 14. Global LDL Apheresis Therapy Sales by Manufacturers (2016-2021) & (K Units) Table 15. Global LDL Apheresis Therapy Sales Share by Manufacturers (2016-2021) Table 16. Global LDL Apheresis Therapy Revenue by Manufacturers (2016-2021) & (US$ Million) Table 17. Global LDL Apheresis Therapy Revenue Share by Manufacturers (2016-2021) Table 18. LDL Apheresis Therapy Price by Manufacturers 2016-2021 (US$/Unit) Table 19. Global LDL Apheresis Therapy Manufacturers Market Concentration Ratio (CR5 and HHI) Table 20. Global LDL Apheresis Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LDL Apheresis Therapy as of 2020) Table 21. LDL Apheresis Therapy Manufacturing Base Distribution and Headquarters Table 22. Manufacturers LDL Apheresis Therapy Product Offered Table 23. Date of Manufacturers Enter into LDL Apheresis Therapy Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global LDL Apheresis Therapy Sales by Type (2016-2021) & (K Units) Table 26. Global LDL Apheresis Therapy Sales by Type (2022-2027) & (K Units) Table 27. Global LDL Apheresis Therapy Sales Share by Type (2016-2021) Table 28. Global LDL Apheresis Therapy Sales Share by Type (2022-2027) Table 29. Global LDL Apheresis Therapy Revenue by Type (2016-2021) & (US$ Million) Table 30. Global LDL Apheresis Therapy Revenue by Type (2022-2027) & (US$ Million) Table 31. Global LDL Apheresis Therapy Revenue Share by Type (2016-2021) Table 32. Global LDL Apheresis Therapy Revenue Share by Type (2022-2027) Table 33. LDL Apheresis Therapy Price by Type (2016-2021) & (US$/Unit) Table 34. Global LDL Apheresis Therapy Price Forecast by Type (2022-2027) & (US$/Unit) Table 35. Global LDL Apheresis Therapy Sales by Application (2016-2021) & (K Units) Table 36. Global LDL Apheresis Therapy Sales by Application (2022-2027) & (K Units) Table 37. Global LDL Apheresis Therapy Sales Share by Application (2016-2021) Table 38. Global LDL Apheresis Therapy Sales Share by Application (2022-2027) Table 39. Global LDL Apheresis Therapy Revenue by Application (2016-2021) & (US$ Million) Table 40. Global LDL Apheresis Therapy Revenue by Application (2022-2027) & (US$ Million) Table 41. Global LDL Apheresis Therapy Revenue Share by Application (2016-2021) Table 42. Global LDL Apheresis Therapy Revenue Share by Application (2022-2027) Table 43. LDL Apheresis Therapy Price by Application (2016-2021) & (US$/Unit) Table 44. Global LDL Apheresis Therapy Price Forecast by Application (2022-2027) & (US$/Unit) Table 45. North America LDL Apheresis Therapy Sales by Type (2016-2021) & (K Units) Table 46. North America LDL Apheresis Therapy Sales by Type (2022-2027) & (K Units) Table 47. North America LDL Apheresis Therapy Revenue by Type (2016-2021) & (US$ Million) Table 48. North America LDL Apheresis Therapy Revenue by Type (2022-2027) & (US$ Million) Table 49. North America LDL Apheresis Therapy Sales by Application (2016-2021) & (K Units) Table 50. North America LDL Apheresis Therapy Sales by Application (2022-2027) & (K Units) Table 51. North America LDL Apheresis Therapy Revenue by Application (2016-2021) & (US$ Million) Table 52. North America LDL Apheresis Therapy Revenue by Application (2022-2027) & (US$ Million) Table 53. North America LDL Apheresis Therapy Sales by Country (2016-2021) & (K Units) Table 54. North America LDL Apheresis Therapy Sales by Country (2022-2027) & (K Units) Table 55. North America LDL Apheresis Therapy Revenue by Country (2016-2021) & (US$ Million) Table 56. North America LDL Apheresis Therapy Revenue by Country (2022-2027) & (US$ Million) Table 57. Europe LDL Apheresis Therapy Sales by Type (2016-2021) & (K Units) Table 58. Europe LDL Apheresis Therapy Sales by Type (2022-2027) & (K Units) Table 59. Europe LDL Apheresis Therapy Revenue by Type (2016-2021) & (US$ Million) Table 60. Europe LDL Apheresis Therapy Revenue by Type (2022-2027) & (US$ Million) Table 61. Europe LDL Apheresis Therapy Sales by Application (2016-2021) & (K Units) Table 62. Europe LDL Apheresis Therapy Sales by Application (2022-2027) & (K Units) Table 63. Europe LDL Apheresis Therapy Revenue by Application (2016-2021) & (US$ Million) Table 64. Europe LDL Apheresis Therapy Revenue by Application (2022-2027) & (US$ Million) Table 65. Europe LDL Apheresis Therapy Sales by Country (2016-2021) & (K Units) Table 66. Europe LDL Apheresis Therapy Sales by Country (2022-2027) & (K Units) Table 67. Europe LDL Apheresis Therapy Revenue by Country (2016-2021) & (US$ Million) Table 68. Europe LDL Apheresis Therapy Revenue by Country (2022-2027) & (US$ Million) Table 69. Asia Pacific LDL Apheresis Therapy Sales by Type (2016-2021) & (K Units) Table 70. Asia Pacific LDL Apheresis Therapy Sales by Type (2022-2027) & (K Units) Table 71. Asia Pacific LDL Apheresis Therapy Revenue by Type (2016-2021) & (US$ Million) Table 72. Asia Pacific LDL Apheresis Therapy Revenue by Type (2022-2027) & (US$ Million) Table 73. Asia Pacific LDL Apheresis Therapy Sales by Application (2016-2021) & (K Units) Table 74. Asia Pacific LDL Apheresis Therapy Sales by Application (2022-2027) & (K Units) Table 75. Asia Pacific LDL Apheresis Therapy Revenue by Application (2016-2021) & (US$ Million) Table 76. Asia Pacific LDL Apheresis Therapy Revenue by Application (2022-2027) & (US$ Million) Table 77. Asia Pacific LDL Apheresis Therapy Sales by Region (2016-2021) & (K Units) Table 78. Asia Pacific LDL Apheresis Therapy Sales by Region (2022-2027) & (K Units) Table 79. Asia Pacific LDL Apheresis Therapy Revenue by Region (2016-2021) & (US$ Million) Table 80. Asia Pacific LDL Apheresis Therapy Revenue by Region (2022-2027) & (US$ Million) Table 81. Latin America LDL Apheresis Therapy Sales by Type (2016-2021) & (K Units) Table 82. Latin America LDL Apheresis Therapy Sales by Type (2022-2027) & (K Units) Table 83. Latin America LDL Apheresis Therapy Revenue by Type (2016-2021) & (US$ Million) Table 84. Latin America LDL Apheresis Therapy Revenue by Type (2022-2027) & (US$ Million) Table 85. Latin America LDL Apheresis Therapy Sales by Application (2016-2021) & (K Units) Table 86. Latin America LDL Apheresis Therapy Sales by Application (2022-2027) & (K Units) Table 87. Latin America LDL Apheresis Therapy Revenue by Application (2016-2021) & (US$ Million) Table 88. Latin America LDL Apheresis Therapy Revenue by Application (2022-2027) & (US$ Million) Table 89. Latin America LDL Apheresis Therapy Sales by Country (2016-2021) & (K Units) Table 90. Latin America LDL Apheresis Therapy Sales by Country (2022-2027) & (K Units) Table 91. Latin America LDL Apheresis Therapy Revenue by Country (2016-2021) & (US$ Million) Table 92. Latin America LDL Apheresis Therapy Revenue by Country (2022-2027) & (US$ Million) Table 93. Middle East and Africa LDL Apheresis Therapy Sales by Type (2016-2021) & (K Units) Table 94. Middle East and Africa LDL Apheresis Therapy Sales by Type (2022-2027) & (K Units) Table 95. Middle East and Africa LDL Apheresis Therapy Revenue by Type (2016-2021) & (US$ Million) Table 96. Middle East and Africa LDL Apheresis Therapy Revenue by Type (2022-2027) & (US$ Million) Table 97. Middle East and Africa LDL Apheresis Therapy Sales by Application (2016-2021) & (K Units) Table 98. Middle East and Africa LDL Apheresis Therapy Sales by Application (2022-2027) & (K Units) Table 99. Middle East and Africa LDL Apheresis Therapy Revenue by Application (2016-2021) & (US$ Million) Table 100. Middle East and Africa LDL Apheresis Therapy Revenue by Application (2022-2027) & (US$ Million) Table 101. Middle East and Africa LDL Apheresis Therapy Sales by Country (2016-2021) & (K Units) Table 102. Middle East and Africa LDL Apheresis Therapy Sales by Country (2022-2027) & (K Units) Table 103. Middle East and Africa LDL Apheresis Therapy Revenue by Country (2016-2021) & (US$ Million) Table 104. Middle East and Africa LDL Apheresis Therapy Revenue by Country (2022-2027) & (US$ Million) Table 105. Kaneka Pharma Europe NV Corporation Information Table 106. Kaneka Pharma Europe NV Description and Major Businesses Table 107. Kaneka Pharma Europe NV LDL Apheresis Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 108. Kaneka Pharma Europe NV LDL Apheresis Therapy Product Table 109. Kaneka Pharma Europe NV Recent Developments Table 110. B.Braun Corporation Information Table 111. B.Braun Description and Major Businesses Table 112. B.Braun LDL Apheresis Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 113. B.Braun LDL Apheresis Therapy Product Table 114. B.Braun Recent Developments Table 115. Fresenius Medical Care Corporation Information Table 116. Fresenius Medical Care Description and Major Businesses Table 117. Fresenius Medical Care LDL Apheresis Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 118. Fresenius Medical Care LDL Apheresis Therapy Product Table 119. Fresenius Medical Care Recent Developments Table 120. Asahi Kasei Medical Corporation Information Table 121. Asahi Kasei Medical Description and Major Businesses Table 122. Asahi Kasei Medical LDL Apheresis Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 123. Asahi Kasei Medical LDL Apheresis Therapy Product Table 124. Asahi Kasei Medical Recent Developments Table 125. Medicap Corporation Information Table 126. Medicap Description and Major Businesses Table 127. Medicap LDL Apheresis Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 128. Medicap LDL Apheresis Therapy Product Table 129. Medicap Recent Developments Table 130. Kawasumi Laboratories Corporation Information Table 131. Kawasumi Laboratories Description and Major Businesses Table 132. Kawasumi Laboratories LDL Apheresis Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 133. Kawasumi Laboratories LDL Apheresis Therapy Product Table 134. Kawasumi Laboratories Recent Developments Table 135. Terumo Corporation Corporation Information Table 136. Terumo Corporation Description and Major Businesses Table 137. Terumo Corporation LDL Apheresis Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 138. Terumo Corporation LDL Apheresis Therapy Product Table 139. Terumo Corporation Recent Developments Table 140. Haemonetics Corporation Information Table 141. Haemonetics Description and Major Businesses Table 142. Haemonetics LDL Apheresis Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 143. Haemonetics LDL Apheresis Therapy Product Table 144. Haemonetics Recent Developments Table 145. Key Raw Materials Lists Table 146. Raw Materials Key Suppliers Lists Table 147. LDL Apheresis Therapy Distributors List Table 148. LDL Apheresis Therapy Customers List Table 149. LDL Apheresis Therapy Market Trends Table 150. LDL Apheresis Therapy Market Drivers Table 151. LDL Apheresis Therapy Market Challenges Table 152. LDL Apheresis Therapy Market Restraints Table 153. Research Programs/Design for This Report Table 154. Key Data Information from Secondary Sources Table 155. Key Data Information from Primary Sources List of Figures Figure 1. LDL Apheresis Therapy Product Picture Figure 2. Global LDL Apheresis Therapy Market Share by Type in 2020 & 2027 Figure 3. Double Filtration LDL Apheresis Therapy Product Picture Figure 4. Cascade Filtration LDL Apheresis Therapy Product Picture Figure 5. Global LDL Apheresis Therapy Sales Market Share by Application in 2020 & 2027 Figure 6. Atherosclerosis Patient Figure 7. Obesity Patient Figure 8. Dyslipidemia Patient Figure 9. Coronary Heart Disease Patient Figure 10. Carotid Artery Disease Patient Figure 11. LDL Apheresis Therapy Report Years Considered Figure 12. Global LDL Apheresis Therapy Sales 2016-2027 (K Units) Figure 13. Global LDL Apheresis Therapy Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global LDL Apheresis Therapy Revenue 2016-2027 (US$ Million) Figure 15. Global LDL Apheresis Therapy Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 16. Global LDL Apheresis Therapy Sales Market Share by Region (2016-2021) Figure 17. Global LDL Apheresis Therapy Sales Market Share by Region (2022-2027) Figure 18. North America LDL Apheresis Therapy Sales YoY (2016-2027) & (K Units) Figure 19. North America LDL Apheresis Therapy Revenue YoY (2016-2027) & (US$ Million) Figure 20. Europe LDL Apheresis Therapy Sales YoY (2016-2027) & (K Units) Figure 21. Europe LDL Apheresis Therapy Revenue YoY (2016-2027) & (US$ Million) Figure 22. Asia-Pacific LDL Apheresis Therapy Sales YoY (2016-2027) & (K Units) Figure 23. Asia-Pacific LDL Apheresis Therapy Revenue YoY (2016-2027) & (US$ Million) Figure 24. Latin America LDL Apheresis Therapy Sales YoY (2016-2027) & (K Units) Figure 25. Latin America LDL Apheresis Therapy Revenue YoY (2016-2027) & (US$ Million) Figure 26. Middle East & Africa LDL Apheresis Therapy Sales YoY (2016-2027) & (K Units) Figure 27. Middle East & Africa LDL Apheresis Therapy Revenue YoY (2016-2027) & (US$ Million) Figure 28. The Top 10 and Top 5 Players Market Share by LDL Apheresis Therapy Sales in 2020 Figure 29. The Top 10 and Top 5 Players Market Share by LDL Apheresis Therapy Revenue in 2020 Figure 30. LDL Apheresis Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 31. Global LDL Apheresis Therapy Sales Market Share by Type (2016-2027) Figure 32. Global LDL Apheresis Therapy Revenue Market Share by Type (2016-2027) Figure 33. Global LDL Apheresis Therapy Sales Market Share by Application (2016-2027) Figure 34. Global LDL Apheresis Therapy Revenue Market Share by Application (2016-2027) Figure 35. North America LDL Apheresis Therapy Sales Market Share by Type (2016-2027) Figure 36. North America LDL Apheresis Therapy Revenue Market Share by Type (2016-2027) Figure 37. North America LDL Apheresis Therapy Sales Market Share by Application (2016-2027) Figure 38. North America LDL Apheresis Therapy Revenue Market Share by Application (2016-2027) Figure 39. North America LDL Apheresis Therapy Sales Share by Country (2016-2027) Figure 40. North America LDL Apheresis Therapy Revenue Share by Country (2016-2027) Figure 41. U.S. LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 42. Canada LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 43. Europe LDL Apheresis Therapy Sales Market Share by Type (2016-2027) Figure 44. Europe LDL Apheresis Therapy Revenue Market Share by Type (2016-2027) Figure 45. Europe LDL Apheresis Therapy Sales Market Share by Application (2016-2027) Figure 46. Europe LDL Apheresis Therapy Revenue Market Share by Application (2016-2027) Figure 47. Europe LDL Apheresis Therapy Sales Share by Country (2016-2027) Figure 48. Europe LDL Apheresis Therapy Revenue Share by Country (2016-2027) Figure 49. Germany LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 50. France LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 51. U.K. LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 52. Italy LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 53. Russia LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 54. Asia Pacific LDL Apheresis Therapy Sales Market Share by Type (2016-2027) Figure 55. Asia Pacific LDL Apheresis Therapy Revenue Market Share by Type (2016-2027) Figure 56. Asia Pacific LDL Apheresis Therapy Sales Market Share by Application (2016-2027) Figure 57. Asia Pacific LDL Apheresis Therapy Revenue Market Share by Application (2016-2027) Figure 58. Asia Pacific LDL Apheresis Therapy Sales Share by Region (2016-2027) Figure 59. Asia Pacific LDL Apheresis Therapy Revenue Share by Region (2016-2027) Figure 60. China LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 61. Japan LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 62. South Korea LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 63. India LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 64. Australia LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 65. Taiwan LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 66. Indonesia LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 67. Thailand LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 68. Malaysia LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 69. Philippines LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 70. Latin America LDL Apheresis Therapy Sales Market Share by Type (2016-2027) Figure 71. Latin America LDL Apheresis Therapy Revenue Market Share by Type (2016-2027) Figure 72. Latin America LDL Apheresis Therapy Sales Market Share by Application (2016-2027) Figure 73. Latin America LDL Apheresis Therapy Revenue Market Share by Application (2016-2027) Figure 74. Latin America LDL Apheresis Therapy Sales Share by Country (2016-2027) Figure 75. Latin America LDL Apheresis Therapy Revenue Share by Country (2016-2027) Figure 76. Mexico LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 77. Brazil LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 78. Argentina LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 79. Middle East and Africa LDL Apheresis Therapy Sales Market Share by Type (2016-2027) Figure 80. Middle East and Africa LDL Apheresis Therapy Revenue Market Share by Type (2016-2027) Figure 81. Middle East and Africa LDL Apheresis Therapy Sales Market Share by Application (2016-2027) Figure 82. Middle East and Africa LDL Apheresis Therapy Revenue Market Share by Application (2016-2027) Figure 83. Middle East and Africa LDL Apheresis Therapy Sales Share by Country (2016-2027) Figure 84. Middle East and Africa LDL Apheresis Therapy Revenue Share by Country (2016-2027) Figure 85. Turkey LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 86. Saudi Arabia LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 87. UAE LDL Apheresis Therapy Revenue (2016-2027) & (US$ Million) Figure 88. LDL Apheresis Therapy Value Chain Figure 89. LDL Apheresis Therapy Production Process Figure 90. Channels of Distribution Figure 91. Distributors Profiles Figure 92. Bottom-up and Top-down Approaches for This Report Figure 93. Data Triangulation Figure 94. Key Executives Interviewed

Kaneka Pharma Europe NV B.Braun Fresenius Medical Care Asahi Kasei Medical Medicap Kawasumi Laboratories Terumo Corporation Haemonetics